UPCOMING EDUCATIONJoin ICHS for an interactive, case-based webinar where real-world scenarios set the stage for a dynamic discussion on the latest evidence and the outlook of Helicase Primase Inhibitors (HPIs). This session will reflect the evolution of the field with the future introduction of HPIs, the available clinical evidence, and how these therapies may be integrated into Dr. Roy Chemaly will facilitate a moderated discussion with the presenters to provide attendees with both the scientific rationale and the clinical context for incorporating HPIs into future management strategies for Refractory HSV in immunocompromised patients. During the webinar we will:
Free for ICHS members (log in first for this option.) Non-members: $25USD - includes a one year membership. MORE INFORMATION AND REGISTRATION Contact the ICHS team at admin@ichs.org if you need any assistance. | ICHS MEMBERSHIPJoin over 900 members across 58 countries and gain access to a wealth of resources, networking opportunities, and exclusive benefits tailored to support your professional growth. Enhance patient care by actively engaging with a community of experts. ICHS members receive a reduced registration fee for educational events. New reduced $25 annual membership dues are now offered. For assistance with your membership, please contact us at admin@ichs.org. As a member of ICHS, you will gain access to a wealth of resources, networking opportunities, and exclusive benefits tailored to support your professional growth. ICHS members receive free webinar registrations and a reduced registration fee for educational events. New reduced $25 annual membership dues are now offered. For assistance with your membership, please contact us at admin@ichs.org. | AWARDS SPOTLIGHTCongratulations to the ICHS 2026 Awardees! Awards were presented to individuals for exceptional contributions related to the immunocompromised host field at the ICHS 24th Biennial Symposium. For more information on the awardees, and the exemplary careers, please visit the Awards page. New Award! Visit the Awards pages here for more information: Again, congratulations! |
|
View photos here